Patents by Inventor Richard Steinhardt

Richard Steinhardt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7824847
    Abstract: Tissue preservation media comprising a polyoxyethylene/polyoxypropylene copolymer are used to preserve tissues and organs for storage and transplantation. In particular embodiments, the polyoxyethylene/polyoxypropylene copolymer is Pluronic F68 or FLOCOR (CRL-5861; purified poloxamer 188), and the medium is Steinhardt medium, polyoxyethylene/polyoxypropylene copolymer-supplemented Optisol GS or polyoxyethylene/polyoxypropylene copolymer-supplemented ViaSpan.
    Type: Grant
    Filed: January 17, 2008
    Date of Patent: November 2, 2010
    Assignee: Regents of the University of California
    Inventor: Richard A. Steinhardt
  • Publication number: 20080131866
    Abstract: Tissue preservation media comprising a polyoxyethylene/polyoxypropylene copolymer are used to preserve tissues and organs for storage and transplantation. In particular embodiments, the polyoxyethylene/polyoxypropylene copolymer is Pluronic F68 or FLOCOR (CRL-5861; purified poloxamer 188), and the medium is Steinhardt medium, polyoxyethylene/polyoxypropylene copolymer-supplemented Optisol GS or polyoxyethylene/polyoxypropylene copolymer-supplemented ViaSpan.
    Type: Application
    Filed: January 17, 2008
    Publication date: June 5, 2008
    Inventor: Richard Steinhardt
  • Patent number: 7371513
    Abstract: Tissue preservation media comprising a polyoxyethylene/polyoxypropylene copolymer are used to preserve tissues and organs for storage and transplantation. In particular embodiments, the polyoxyethylene/polyoxypropylene copolymer is Pluronic F68 or FLOCOR (CRL-5861; purified poloxamer 188), and the medium is Steinhardt medium, polyoxyethylene/polyoxypropylene copolymer-supplemented Optisol GS or polyoxyethylene/polyoxypropylene copolymer-supplemented ViaSpan.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: May 13, 2008
    Assignee: Regents of the University of California
    Inventor: Richard A. Steinhardt
  • Patent number: 7087369
    Abstract: Steinhardt defined medium preserves cornea tissue during cold storage. Tissue preservation kits comprise a premeasured amount of Steinhardt's medium and copackaged instructions describing use of the medium to preserve a tissue. Kits for making Steinhardt medium comprise premeasured amounts of medium ingredients; and copackaged instructions describing how to combine the ingredients to make the medium. The medium is made by combining the recited ingredients, and used by incubating a tissue in the medium.
    Type: Grant
    Filed: December 17, 2003
    Date of Patent: August 8, 2006
    Assignee: The Regents of the University of California
    Inventor: Richard A. Steinhardt
  • Publication number: 20050156378
    Abstract: Tissue preservation media comprising a polyoxyethylene/polyoxypropylene copolymer are used to preserve tissues and organs for storage and transplantation. In particular embodiments, the polyoxyethylene/polyoxypropylene copolymer is Pluronic F68 or FLOCOR (CRL-5861; purified poloxamer 188), and the medium is Steinhardt medium, polyoxyethylene/polyoxypropylene copolymer-supplemented Optisol GS or polyoxyethylene/polyoxypropylene copolymer-supplemented ViaSpan.
    Type: Application
    Filed: December 17, 2004
    Publication date: July 21, 2005
    Inventor: Richard Steinhardt
  • Publication number: 20050136391
    Abstract: Steinhardt defined medium preserves cornea tissue during cold storage. Tissue preservation kits comprise a premeasured amount of Steinhardt's medium and copackaged instructions describing use of the medium to preserve a tissue. Kits for making Steinhardt medium comprise premeasured amounts of medium ingredients; and copackaged instructions describing how to combine the ingredients to make the medium. The medium is made by combining the recited ingredients, and used by incubating a tissue in the medium.
    Type: Application
    Filed: December 17, 2003
    Publication date: June 23, 2005
    Inventor: Richard Steinhardt
  • Patent number: 5559004
    Abstract: Intracellular free calcium concentrations are lowered by administering certain dihydropyridine derivatives to cells. Dihydropyridine and other test compounds are screened for their ability to lower intracellular free calcium, particularly by inhibiting the influx of calcium through calcium leak channels, and the identified compounds incorporated into pharmaceutical compositions. Exemplary dihydropyridine derivative compounds include 4-(3-trifluoromethylphenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyr idine; 4-(4-bromophenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine; 4-(4-trifluoromethylphenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyr idine; 4-(4-methylphenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine; and 4-(4-cyanophenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine.
    Type: Grant
    Filed: July 12, 1994
    Date of Patent: September 24, 1996
    Assignees: The Regents of the University of California, Athena Neurosciences, Inc.
    Inventors: Richard A. Steinhardt, Varghese John, Lawrence C. Fritz